1. Home
  2. BDSX vs RLTY Comparison

BDSX vs RLTY Comparison

Compare BDSX & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
    SELLHOLDBUYas of 5 hours ago
  • RLTY
    SELLHOLDBUYas of 5 hours ago
  • Stock Information
  • Founded
  • BDSX 2005
  • RLTY 2022
  • Country
  • BDSX United States
  • RLTY United States
  • Employees
  • BDSX N/A
  • RLTY N/A
  • Industry
  • BDSX Precision Instruments
  • RLTY Investment Managers
  • Sector
  • BDSX Health Care
  • RLTY Finance
  • Exchange
  • BDSX Nasdaq
  • RLTY Nasdaq
  • Market Cap
  • BDSX 215.3M
  • RLTY 256.9M
  • IPO Year
  • BDSX 2020
  • RLTY N/A
  • Fundamental
  • Price
  • BDSX $1.30
  • RLTY $14.47
  • Analyst Decision
  • BDSX Strong Buy
  • RLTY
  • Analyst Count
  • BDSX 4
  • RLTY 0
  • Target Price
  • BDSX $3.08
  • RLTY N/A
  • AVG Volume (30 Days)
  • BDSX 261.2K
  • RLTY 86.7K
  • Earning Date
  • BDSX 02-28-2025
  • RLTY 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • RLTY 9.35%
  • EPS Growth
  • BDSX N/A
  • RLTY N/A
  • EPS
  • BDSX N/A
  • RLTY N/A
  • Revenue
  • BDSX $65,562,000.00
  • RLTY N/A
  • Revenue This Year
  • BDSX $46.97
  • RLTY N/A
  • Revenue Next Year
  • BDSX $30.43
  • RLTY N/A
  • P/E Ratio
  • BDSX N/A
  • RLTY N/A
  • Revenue Growth
  • BDSX 48.92
  • RLTY N/A
  • 52 Week Low
  • BDSX $1.11
  • RLTY $11.38
  • 52 Week High
  • BDSX $2.21
  • RLTY $14.60
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 55.39
  • RLTY 33.07
  • Support Level
  • BDSX $1.43
  • RLTY $14.58
  • Resistance Level
  • BDSX $1.55
  • RLTY $15.11
  • Average True Range (ATR)
  • BDSX 0.10
  • RLTY 0.33
  • MACD
  • BDSX 0.00
  • RLTY 0.00
  • Stochastic Oscillator
  • BDSX 59.83
  • RLTY 36.53

Stock Price Comparison Chart: BDSX vs RLTY

BDSX
RLTY
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022242628BDSX VS RLTY

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use